Literature DB >> 11450894

Modulation of Akt activity by doxorubicin in breast cancer cells.

A M Tari, A Mehta, G Lopez-Berestein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11450894     DOI： 10.1179/joc.2001.13.3.334

Source DB:  PubMed          Journal:  J Chemother        ISSN： 1120-009X            Impact factor:   1.714


× No keyword cloud information.
  3 in total

1.  Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.

Authors:  Ahmed F Salem; Gloria Bonuccelli; Generoso Bevilacqua; Hwyda Arafat; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.

Authors:  Xinqun Li; Yang Lu; Ke Liang; Bolin Liu; Zhen Fan
Journal:  Breast Cancer Res       Date:  2005-05-24       Impact factor: 6.466

3.  MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.

Authors:  Andrea Turner; Liang-Cheng Li; Tania Pilli; Lixia Qian; Elizabeth Louise Wiley; Suman Setty; Konstantin Christov; Lakshmy Ganesh; Ajay V Maker; Peifeng Li; Prasad Kanteti; Tapas K Das Gupta; Bellur S Prabhakar
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.